ReviewFood science & nutrition2026
Effects of Canola Oil on Hepatic and Cardiometabolic Markers in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Review in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity, insulin resistance, and increased cardiometabolic risk. Dietary fat quality has emerged as a modifiable factor in NAFLD management; however, the specific effects of canola oil on hepatic and metabolic markers remain unclear. This systematic review and meta-analysis evaluated randomized controlled trials investigating the effects of canola oil consumption in adults with NAFLD. Searches were conducted in PubMed, Web of Science, Scopus, and Cochrane Library databases through December 2024 in accordance with PRISMA guidelines (PROSPERO: CRD42024593566). Random-effects models were applied to estimate pooled effect sizes. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool, and certainty of evidence was graded using the GRADE framework. Three randomized controlled trials (four intervention arms;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.